Interestingly, the authors also found that drugs used to prevent Malaria and pneumocystis pneumonia (PCP) relapses, such as Primaquine, have therapeutic potential against SARS-CoV-2 based on the interaction of Primaquine with the TIM complex, consisting of TIMM29 and ALG11. The gene discussed is ALG11; the disease is pneumocystosis.